Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Vanda Appeals FDA’s Denial Of Hetlioz Jet Lag Application As It Is Hit With CRL For Insomnia
Mar 07 2024
•
By
Brenda Sandburg
US FDA rejects Vanda's application for a jet lag indication for Hetlioz and issues complete response letter on insomnia application • Source: Shutterstock
More from Approval Standards
More from Pathways & Standards